Anatomic Pathology: Unveiling Insights into a Vital Medical Specialty
 |
Overview of Anatomic Pathology
Anatomic
pathology is a medical specialty that emphasizes the examination of tissue
samples and cells to identify and study diseases. It is also known as
anatomical pathology. It includes the analysis of biological samples obtained
from patients, which can include biopsies, surgical specimens, and autopsy
tissues. It plays a key role in the diagnosis, prognosis, and management of
several diseases, including cancer. Also, the anatomic pathology sector
includes various sub-disciplines, that include surgical pathology,
cytopathology, and autopsy pathology. Further, examples of anatomic pathology
include types of kidney disease (glomerulonephritis), lung (pulmonary) diseases
(asbestosis), or aggressive cancers that lose their normal proteins.
Key Applications of Anatomic Pathology:
- Diagnosis,
prognosis, and management of diseases.
- Examination of
tissue samples and cells.
Global Market Landscape
According to a
fresh report published by Emergen Research, the global
Anatomic Pathology Market size was USD 35.33 Billion in 2021 and is
expected to reach a CAGR of 7.0% over the assessment period. Also, the report
contains several market predictions related to production, Consumption, gross
margin, price, and other substantial factors. While highlighting the key
driving and restraining forces for this market, the report also offers a
complete study of the future trends and developments of the market.
The market
includes news and updates about the market's current situation, historic data,
and present market trends, and this factor which is valuable and supportive to
the business. It also examines the role of the leading market players involved
in the industry including their corporate overview, financial summary, and SWOT
analysis.
Market Highlights:
- Global market
size of USD 35.33 Billion in 2021
- Expected CAGR
of 7.0% during the assessment period
Factors Driving Industry Growth
Several factors contribute to the expansion of the anatomic pathology
industry:
Increasing Frequency of Chronic Diseases:
The growing
frequency of chronic diseases such as cancer, cardiovascular diseases, and
neurological disorders are propelling the growth of the global anatomic
pathology market size as the pathological examinations, including tissue
biopsies and cytology, play a crucial role in the diagnosis and treatment of
these diseases.
Aging Population:
The rising old
age population is another factor enhancing the industry demand as elderly
individuals are more susceptible to conditions such as cancer and degenerative
diseases.
Technological Advancements:
Advancement in
technology is considered the major factor anticipated to uplift the growth of
the global market over the foreseen period as digital pathology, automation,
and image analysis tools have improved accuracy, efficiency, and speed in the
diagnosis process.
Global Healthcare Expenditure:
Increasing
healthcare expenditure across the globe is driving the growth of the industry
and is expected to maintain its dominance over the assessment period. The major
factors accountable for the growth expansion are improved access to healthcare,
economic growth, and expanding insurance coverage.
Focus on Personalized Medicine:
Further, a
growing focus on personalized medicine is anticipated to boost the global
market growth over the foreseen period as anatomic pathology plays a crucial
role in identifying specific biomarkers and genetic mutations that influence
disease progression and treatment response.
Challenges and Limitations
However,
reimbursement challenges and a stringent regulatory environment are the major
factors restricting the growth of the global market. Also, the absence of
skilled pathologists and limited awareness and adoption are the other factors
expected to hinder the growth of the anatomic pathology market over the
assessment period.
Noteworthy Industry Developments
Hologic received
FDA premarket approval (PMA) for its ThinPrep GenesisTM processor for cytology
processing and specimen transfer for downstream applications in May 2021.
Additionally,
PHC Holding Corporation completed the acquisition of Thermo Fisher Scientific's
Anatomical Pathology business in January 2019 in order to strengthen its
position in the diagnostics segment.
Key Industry Players
Major companies contributing to the Anatomic Pathology market include:
- F. Hoffmann-La
Roche Ltd. (Switzerland)
- Mylan N.V.
(U.S.)
- Teva
Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Pfizer Inc.
(U.S.)
- GlaxoSmithKline
plc (U.K.)
- Novartis AG
(Switzerland)
- Bayer AG
(Germany)
- Eli Lilly and
Company (U.S.)
- Merck &
Co., Inc. (U.S.)
- Allergan
(Ireland)
- AstraZeneca
(U.K.)
- Johnson &
Johnson Private Limited (U.S.)
- Cipla Inc.
(U.S.)
- Bausch Health
Companies Inc. (Canada)
- Abbott (U.S.)
Get insider
access! Sign up today for a complimentary sample and explore more@
